ASCF(SH:600855)2024-10-29 08:55Financial Performance - The company's operating revenue for Q3 2024 was ¥170,118,350.75, a decrease of 44.94% compared to the same period last year[2]. - The net profit attributable to shareholders for Q3 2024 was -¥47,401,853.57, with a year-to-date net profit of -¥99,446,425.41, reflecting a decrease of 23.47% year-on-year[2]. - Total operating revenue for the first three quarters of 2024 was CNY 657.74 million, a decrease of 23.5% compared to CNY 859.48 million in the same period of 2023[16]. - Net profit for the first three quarters of 2024 was a loss of CNY 103.59 million, compared to a loss of CNY 79.33 million in the same period of 2023[18]. - Total comprehensive income for the third quarter of 2024 was -103,592,889.74 RMB, compared to -79,328,447.66 RMB in the same period of 2023, reflecting a decline[19]. - Operating profit for the first three quarters of 2024 was a loss of CNY 41,298,090.04, compared to a profit of CNY 19,556,212.41 in the same period of 2023[26]. - Net profit for the first three quarters of 2024 was a loss of CNY 35,188,182.71, compared to a profit of CNY 21,031,756.03 in the same period of 2023[26]. Assets and Liabilities - Total assets at the end of Q3 2024 were ¥3,887,582,695.84, a decrease of 2.40% from the end of the previous year[3]. - The company's total liabilities as of the end of the third quarter of 2024 were CNY 1.99 billion, slightly up from CNY 1.99 billion at the end of 2023[15]. - Total assets decreased to CNY 2,292,671,307.54 in Q3 2024 from CNY 2,376,507,108.36 in Q3 2023, a decline of approximately 3.5%[24]. - Total liabilities decreased to CNY 150,853,345.62 in Q3 2024 from CNY 198,903,811.74 in Q3 2023, a decline of approximately 24.2%[24]. - Current liabilities totaled CNY 107,756,145.67 in Q3 2024, down from CNY 152,861,013.20 in Q3 2023, a decrease of approximately 29.5%[24]. - The company's total equity decreased to CNY 2,141,817,961.92 in Q3 2024 from CNY 2,177,603,296.62 in Q3 2023, a decline of approximately 1.6%[24]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 53,870[8]. - The largest shareholder, China Aerospace Science and Industry Corporation, holds 30.13% of the shares, totaling 141,150,722 shares[8]. - The total equity attributable to shareholders of the parent company was CNY 1.76 billion, down from CNY 1.85 billion in the previous year[15]. Cash Flow and Investments - Cash flow from operating activities showed a net outflow of -47,099,581.90 RMB, an improvement from -195,744,661.55 RMB in the same period last year[20]. - The company reported cash and cash equivalents of 797,726,523.73 RMB at the end of September 2024, a decrease from 780,223,091.96 RMB at the end of September 2023[21]. - The company received 3,051,391.33 RMB from investment activities, a significant decrease from 345,937,595.22 RMB in the previous year[21]. - The net cash flow from financing activities was -60,234,980.91 RMB, compared to a positive 294,205,350.00 RMB in the same period last year[21]. - The company reported a total cash outflow from financing activities of 49,903,941.68 RMB, while the previous year recorded an inflow of 287,105,330.23 RMB[29]. Revenue by Business Segment - High-end medical equipment business revenue decreased by 87.10% year-on-year, primarily due to a reduction in new contracts signed in 2024[7]. - The military electronics business revenue declined by 15.11% year-on-year, influenced by a decrease in customer orders[7]. Research and Development - The company has ongoing research and development efforts, although specific new products or technologies were not detailed in the report[11]. - Research and development expenses for the first three quarters of 2024 were CNY 63.55 million, a decrease from CNY 67.24 million in the same period of 2023[18]. - Research and development expenses for the first three quarters of 2024 were CNY 15,212,686.06, down from CNY 20,377,492.00 in the same period of 2023[26]. Cost Management - Total operating costs for the first three quarters of 2024 were CNY 770.31 million, down 19.9% from CNY 962.18 million in the previous year[16]. - The company’s management expenses decreased to CNY 138.97 million from CNY 167.62 million year-over-year, reflecting cost control measures[16]. - The company’s sales expenses for the first three quarters of 2024 were CNY 77.30 million, down from CNY 96.69 million in the same period of 2023[16].